
CalciMedica, Inc.
CalciMedica, Inc. (CALC) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CALC · as of Jun 9, 2026
Activity summary
Buy transactions
29
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
29.00
Buy/Sell (by trades)
Overall sentiment
CalciMedica, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CALC insider buying and selling by quarter
CALC insider selling · CALC insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · CALC ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CALC executive sell shares · CALC board member insider trading · CALC insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 18, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 2,500 | $8K | Form 4 |
| Sep 15, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 3,400 | $9K | Form 4 |
| Sep 12, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 5,000 | $16K | Form 4 |
| Sep 9, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 2,343 | $7K | Form 4 |
| Aug 29, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 800 | $2K | Form 4 |
| Aug 28, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 9,200 | $26K | Form 4 |
| Aug 21, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 3,508 | $10K | Form 4 |
| Aug 20, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Option | 15,000 | $23K | Form 4 |
| Aug 20, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 2,000 | $5K | Form 4 |
| Aug 19, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 1,000 | $3K | Form 4 |
| Aug 19, 2025 | Hebbar Sudarshan Chief Medical Officer | Purchase | 9,563 | $27K | Form 4 |
| Aug 15, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 5,076 | $15K | Form 4 |
| Aug 15, 2025 | Hebbar Sudarshan Chief Medical Officer | Purchase | 4,392 | $12K | Form 4 |
| Aug 14, 2025 | Hebbar Sudarshan Chief Medical Officer | Purchase | 1,584 | $4K | Form 4 |
| Jul 28, 2025 | Stauderman Kenneth A. Chief Scientific Officer | Purchase | 1,000 | $4K | Form 4 |
| Jul 25, 2025 | Stauderman Kenneth A. Chief Scientific Officer | Sale | 1,000 | $4K | Form 4 |
| Jul 22, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 1,500 | $6K | Form 4 |
| Jul 21, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 1,500 | $5K | Form 4 |
| Jul 21, 2025 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER · Director | Purchase | 1,000 | $3K | Form 4 |
| Jul 18, 2025 | WILSON ROBERT N Director | Purchase | 4,500 | $13K | Form 4 |
| Jul 18, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 2,000 | $6K | Form 4 |
| Jul 14, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 6,500 | $16K | Form 4 |
| Jul 14, 2025 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER · Director | Purchase | 2,500 | $6K | Form 4 |
| Jul 9, 2025 | Roberts Eric W CHIEF BUSINESS OFFICER · Director | Purchase | 5,000 | $8K | Form 4 |
| Jul 1, 2025 | Stauderman Kenneth A. Chief Scientific Officer | Purchase | 1,000 | $2K | Form 4 |
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Sep 18
Shares
2,500
Price
$3.07
Value
$8K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Sep 15
Shares
3,400
Price
$2.68
Value
$9K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Sep 12
Shares
5,000
Price
$3.12
Value
$16K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Sep 9
Shares
2,343
Price
$3.15
Value
$7K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Aug 29
Shares
800
Price
$2.74
Value
$2K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Aug 28
Shares
9,200
Price
$2.86
Value
$26K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Aug 21
Shares
3,508
Price
$2.79
Value
$10K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Aug 20
Shares
15,000
Price
$1.53
Value
$23K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Aug 20
Shares
2,000
Price
$2.72
Value
$5K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Aug 19
Shares
1,000
Price
$2.79
Value
$3K
Hebbar Sudarshan
Chief Medical Officer
Date
Aug 19
Shares
9,563
Price
$2.82
Value
$27K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Aug 15
Shares
5,076
Price
$2.90
Value
$15K
Hebbar Sudarshan
Chief Medical Officer
Date
Aug 15
Shares
4,392
Price
$2.79
Value
$12K
Hebbar Sudarshan
Chief Medical Officer
Date
Aug 14
Shares
1,584
Price
$2.58
Value
$4K
Stauderman Kenneth A.
Chief Scientific Officer
Date
Jul 28
Shares
1,000
Price
$3.96
Value
$4K
Stauderman Kenneth A.
Chief Scientific Officer
Date
Jul 25
Shares
1,000
Price
$3.65
Value
$4K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Jul 22
Shares
1,500
Price
$3.77
Value
$6K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Jul 21
Shares
1,500
Price
$3.37
Value
$5K
Leheny A. Rachel
CHIEF EXECUTIVE OFFICER · Director
Date
Jul 21
Shares
1,000
Price
$3.40
Value
$3K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Jul 18
Shares
2,000
Price
$2.88
Value
$6K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Jul 14
Shares
6,500
Price
$2.43
Value
$16K
Leheny A. Rachel
CHIEF EXECUTIVE OFFICER · Director
Date
Jul 14
Shares
2,500
Price
$2.47
Value
$6K
Roberts Eric W
CHIEF BUSINESS OFFICER · Director
Date
Jul 9
Shares
5,000
Price
$1.60
Value
$8K
Stauderman Kenneth A.
Chief Scientific Officer
Date
Jul 1
Shares
1,000
Price
$1.85
Value
$2K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CALC insider trading
CALC insider trades
CalciMedica, Inc. (CALC) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Roberts Eric W (CHIEF BUSINESS OFFICER · Director), Hebbar Sudarshan (Chief Medical Officer), Stauderman Kenneth A. (Chief Scientific Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. CALC insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For CalciMedica, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CALC insider trading · 5 questionsThe insiders of CalciMedica, Inc. (CALC) include executives and directors such as Roberts Eric W (CHIEF BUSINESS OFFICER · Director), Hebbar Sudarshan (Chief Medical Officer), Stauderman Kenneth A. (Chief Scientific Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026